These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34822132)

  • 21. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience.
    Frigerio M; Lunati M; Pasqualucci D; Vargiu S; Foti G; Pedretti S; Vittori C; Cattafi G; Magenta G; Campo C; Bisetti S; Mercuro G
    Int J Cardiol; 2014 Mar; 172(1):64-71. PubMed ID: 24456869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy.
    Stassen J; Galloo X; Chimed S; Hirasawa K; Marsan NA; Delgado V; van der Bijl P; Bax JJ
    Eur Heart J Cardiovasc Imaging; 2022 Jun; 23(6):730-740. PubMed ID: 35213709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
    Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
    Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left atrial size and function as assessed by computed tomography in cardiac resynchronization therapy: Association to echocardiographic and clinical outcome.
    Hansen PB; Sommer A; Nørgaard BL; Kronborg MB; Nielsen JC
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):917-925. PubMed ID: 28124231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of long-term mortality with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block.
    Biton Y; Costa J; Zareba W; Baman JR; Goldenberg I; McNitt S; Solomon SD; Polonsky B; Kutyifa V
    Clin Cardiol; 2018 Oct; 41(10):1358-1366. PubMed ID: 30141210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Piccolo R; Galasso G; Reiter RJ
    Int J Cardiol; 2016 Oct; 221():359-63. PubMed ID: 27404706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac resynchronization therapy restored ventricular septal myocardial perfusion and enhanced ventricular remodeling in patients with nonischemic cardiomyopathy presenting with left bundle branch block.
    Ogano M; Iwasaki YK; Tanabe J; Takagi H; Umemoto T; Hayashi M; Miyauchi Y; Shimizu W
    Heart Rhythm; 2014 May; 11(5):836-41. PubMed ID: 24561161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The QRS narrowing index predicts reverse left ventricular remodeling following cardiac resynchronization therapy.
    Rickard J; Popovic Z; Verhaert D; Sraow D; Baranowski B; Martin DO; Lindsay BD; Varma N; Tchou P; Grimm RA; Wilkoff BL; Chung MK
    Pacing Clin Electrophysiol; 2011 May; 34(5):604-11. PubMed ID: 21276023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radial strain delay based on segmental timing and strain amplitude predicts left ventricular reverse remodeling and survival after cardiac resynchronization therapy.
    Kydd AC; Khan FZ; O'Halloran D; Pugh PJ; Virdee MS; Dutka DP
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):177-84. PubMed ID: 23363579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left atrial strain is a predictor of left ventricular systolic and diastolic reverse remodelling in CRT candidates.
    Galli E; Oger E; Aalen JM; Duchenne J; Larsen CK; Sade E; Hubert A; Gallard A; Penicka M; Linde C; Le Rolle V; Hernandez A; Leclercq C; Voigt JU; Smiseth OA; Donal E
    Eur Heart J Cardiovasc Imaging; 2022 Sep; 23(10):1373-1382. PubMed ID: 34432006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pacing leads.
    Rickard J; Johnston DR; Price J; Tedford R; Baranowski B; Bassiouny M; Cantillon D; Grimm RA; Tang WHW; Varma N; Wilkoff BL
    Heart Rhythm; 2015 Mar; 12(3):517-523. PubMed ID: 25460866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular remodelling and change in left ventricular global longitudinal strain after cardiac resynchronization therapy: prognostic implications.
    van der Bijl P; Kostyukevich MV; Khidir M; Ajmone Marsan N; Delgado V; Bax JJ
    Eur Heart J Cardiovasc Imaging; 2019 Oct; 20(10):1112-1119. PubMed ID: 31329827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
    Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
    Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of cardiac resynchronization therapy: mechanical resynchronization and reverse left ventricular remodeling are predictive for long-term transplant-free survival.
    Faber L; Vlachojannis M; Oldenburg O; Hering D; Bogunovic N; Horstkotte D; Lamp B
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1341-50. PubMed ID: 21964638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).
    Goldenberg I; Moss AJ; Hall WJ; Foster E; Goldberger JJ; Santucci P; Shinn T; Solomon S; Steinberg JS; Wilber D; Barsheshet A; McNitt S; Zareba W; Klein H;
    Circulation; 2011 Oct; 124(14):1527-36. PubMed ID: 21900084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Right heart function interacts with left ventricular remodeling after CRT: A pressure volume loop study.
    Schmeisser A; Rauwolf T; Ghanem A; Groscheck T; Adolf D; Grothues F; Fischbach K; Kosiek O; Huth C; Kropf S; Lange S; Luani B; Smid J; Schäfer MH; Schreiber J; Tanev I; Wengler F; Yeritsyan NB; Steendijk P; Braun-Dullaeus RC
    Int J Cardiol; 2018 Oct; 268():156-161. PubMed ID: 29548538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.